Boothbay Fund Management »

Arrowhead Pharmaceuticals shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.9M 83k 34.49
2025-06-30 $979k 62k 15.80
2023-06-30 $945k 27k 35.66

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Slate Path Capital
Geode Capital Management
Siren
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Ubs Global Asset Management Americas
Baker Bros. Advisors
Marshall Wace
Charles Schwab Investment Management

View all funds holding Arrowhead Pharmaceuticals